iCubate Receives CE Mark for the iC-GPC Assay™ for use on the iC-System™ iCubate’s platform and initial assay now available for European clinical laboratory use Huntsville, Ala. August 22, 2017 – iCubate, Inc., an innovative molecular diagnostic device company, announced today that it has received CE Mark for its iCubate...
Read moreiCubate® Earns FDA Clearance for A Unique Diagnostic Solution for the diagnosis of Bloodstream Infections iCubate’s “ARMPCR” technology, integrated platform and initial assay now available for United States Clinical Laboratories Huntsville, Ala. August 10, 2017 – iCubate®, Inc., an innovative molecular diagnostic device company, announced today that it has earned...
Read moreHuntsville, Ala. — October 6, 2016 —iCubate®, a molecular diagnostic company, has formed a Scientific Advisory Board to advance the company’s goal of developing and marketing technologies and products for personalized diagnostics. The advisory board will work with iCubate’s board and management team to ensure the company continues to develop...
Read moreResearchers have identified a potential way to prevent chronic urinary tract infections (UTIs). Their research points to a key protein that bacteria use to latch onto the bladder and cause UTIs, according to scientists at Washington University School of Medicine in St. Louis. Vaccinating mice against the protein reduces the...
Read moreEDPA’s Alabama Launchpad presents Innovation Awards, celebrates entrepreneurship from Alabama NewsCenter on Vimeo. Andrew Yang, founder and CEO of Venture for America, said during his keynote address that Birmingham is the best-kept secret in the innovation and entrepreneurship world because of the level of support and activity he has...
Read moreHuntsville, Ala. -iCubate, Incorporated, a privately held molecular diagnostic company, has won the Frost and Sullivan 2012 North American Product Innovation Award in PCR Technology. “We are honored to be recognized by Frost and Sullivan for this prestigious award,” said Carter Wells, iCubate’s chief executive officer. “iCubate will bring a...
Read moreNo one can imagine biotech without PCR. There are many variations of the basic PCR technology, just visit the Wikipedia link, to find more than 20 different PCR based methods. qPCR or real time PCR, is one of the most popular technologies today. It is popular because it has several...
Read morePPI stands for polymerase preference index (patent pending). It is an algorithm we developed to help select the best performing PCR primers based on polymerase preference. Most of the primer design softwares evaluate the melting temperature (TM) as the most important parameter. But TM, at its best, could only tell...
Read moreiCubate 2.0 is an idea we borrowed from the IT industry where the Web 2.0 business model has already transformed our lives. Here, the “2.0” means “user generated content and an online store”. So, iCubate 2.0 is an open platform that allow users to develop and market multiplex PCR (mPCR)...
Read moreWalking into a clinical molecular diagnostic lab, you will see many boring, gray, ugly shaped machines. It seams nobody is willing to make that little extra effort to design a better looking instrument. The plastic shells are almost always an after thought, simply to cover up the guts. With iCubate,...
Read more